Two Loyola hospitals achieve national recognition for commitment to excellence in cardiovascular care

CONTACT:

Allison Peters 
allison.peters@luhs.org
708-216-5500

MAYWOOD, IL – Loyola University Medical Center (LUMC) and Loyola Medicine’s MacNeal Hospital have earned the American Heart Association Get With The Guidelines® Stroke Gold Plus with Target: Stroke Honor Roll Elite quality achievement award for demonstrating a commitment to following up-to-date, research-based guidelines for the treatment of heart disease and stroke, helping save lives, support recovery and reduce hospital readmissions. The AHA also named LUMC and MacNeal to its Target: Type 2 Diabetes Honor Roll.

LUMC and MacNeal Hospital recognized for advanced care in treating heart disease, stroke and diabetes

The Stroke Gold Plus Award recognizes hospitals for adherence to the AHA’s in-hospital program for improving stroke care, based on the latest scientific treatment guidelines. The Type 2 Diabetes Honor Roll distinction honors hospitals engaging in advanced care for patients with stroke and/or type 2 diabetes. Both LUMC and MacNeal earned the Target: Stroke Elite Honor Roll award by meeting specific criteria that reduce the time between an eligible patient’s arrival at the hospital and treatment to remove the clot causing the stroke.

Heart disease and stroke are the No. 1 and No. 4 causes of death in the United States, respectively, according to the American Heart Association’s 2026 Heart Disease and Stroke Statistics Report. Studies show patients can experience better outcomes when care teams consistently follow evidence-based treatment guidelines. 

Loyola Medicine hospitals have demonstrated an unwavering commitment to quality patient care

Get With The Guidelines puts the expertise of the American Heart Association and American Stroke Association to work for hospitals nationwide, helping ensure patient care is aligned with the latest science-backed guidelines. As a participant in the Get With The Guidelines programs, LUMC and MacNeal qualified for the awards by demonstrating a sustained commitment to improving the quality of cardiovascular care.

"At Loyola Medicine, our mission is to provide exceptional care that helps patients achieve the best possible outcomes,” said Shawn P. Vincent, president and CEO of Loyola Medicine. “We are honored to have two of our hospitals recognized for excellence in the treatment of heart failure, stroke and type 2 diabetes. This recognition highlights the unwavering commitment of our care teams to delivering timely, compassionate and evidence-based care when patients need it most.”

“These awards reflect Loyola Medicine's commitment to caring for people in their community who need cardiovascular care,” said Karen E. Joynt Maddox, M.D., MPH, chair of the American Heart Association Quality Oversight Committee. “By following the American Heart Association’s quality improvement protocols, Loyola can help advance our shared vision of better patient outcomes, fewer readmissions and lower mortality rates — a win for patients, families and health care systems.”